Buscar
redaccion@cronicadechihuahua.com
Buscar
22 de febrero de 2021, 11:05, por Joaquin
How do I get an outside line? buy himplasia baikal-pharmacy.com ** Generic drugmaker Mylan Inc has won U.S.antitrust approval to buy Agila, a unit of India’s StridesArcolab Ltd, subject to divesting some products, theFederal Trade Commission said on Thursday. The companies willhave to divest assets needed to make 11 generic injectible drugsas a condition for approving the deal, the FTC said. The dealfor Agila was valued at $1.6 billion when it was announced inFebruary.
La Crónica de Chihuahua es un diario independiente, enfocado a describir las singularidades y la cotidianidad de la comunidad chihuahuense.